Valuation: Aprogen Biologics Inc.

Market Cap 25.31B 18.8M 16.7M 15.59M 14.21M 26.79M 1.81B 27.04M 189M 73.09M 924M 70.57M 69.04M 2.96B P/E 2024
-0.79x
P/E 2025 -0.6x
Enterprise Value 202B 150M 134M 125M 114M 214M 14.45B 216M 1.51B 585M 7.39B 564M 552M 23.71B EV / Sales 2024
3.66x
EV / Sales 2025 3.82x
Free-Float
43.05%
Yield 2024 *
-
Yield 2025 -
1 day+1.03%
1 week-4.58%
Current month+6.39%
1 month-9.44%
3 months-25.70%
6 months-60.95%
Current year-79.91%
1 week 1,446
Extreme 1446
1,725
1 month 1,446
Extreme 1446
1,940
Current year 1,446
Extreme 1446
8,490
1 year 1,446
Extreme 1446
9,945
3 years 1,446
Extreme 1446
60,600
5 years 1,446
Extreme 1446
155,250
10 years 1,446
Extreme 1446
858,000
Manager TitleAgeSince
Chief Executive Officer 63 2023-10-12
Chief Executive Officer 70 2012-03-31
Sales & Marketing 62 -
Director TitleAgeSince
Director/Board Member 70 2012-03-31
Director/Board Member 65 2020-03-22
Director/Board Member 63 2023-10-12
Date Insider Type Main position Quantity % Market Cap. Importance
6/28/24 Exercice

Executive/Senior Manager

6,183 0.0046%
6/28/24 Expiration

Chief Executive Officer

21,884 0.0164%
6/28/24 Exercice 11,846 0.0089% -
Change 5-day change 1-year change 3-year change Capi.($)
+1.03%-4.58%-82.79%-97.19% 18.8M
-0.61%-3.43%+36.07%+117.61% 1,019B
-1.02%-5.60%+35.72%+64.82% 617B
+1.11%-0.58%+12.36%+78.27% 464B
+0.34%-3.01%+61.79%+41.79% 356B
-0.95%-4.05%+20.54%+40.33% 333B
-1.46%-2.89%+10.57%+26.54% 267B
-1.35%-5.43%-6.17%+8.82% 244B
-1.04%-2.79%+35.30%+54.42% 218B
-1.87%-4.10%+28.44%+97.54% 179B
Average -0.58%-3.08%+15.18%+43.29% 369.72B
Weighted average by Cap. -0.60%-3.33%+29.07%+71.15%

Financials

2024 2025
Net sales 67.38B 50.03M 44.45M 41.49M 37.82M 71.32M 4.81B 71.98M 502M 195M 2.46B 188M 184M 7.89B 73.23B 54.37M 48.31M 45.09M 41.1M 77.51M 5.23B 78.23M 546M 211M 2.67B 204M 200M 8.58B
Net income -105B -77.95M -69.26M -64.64M -58.92M -111M -7.49B -112M -782M -303M -3.83B -293M -286M -12.29B -170B -126M -112M -105M -95.6M -180M -12.16B -182M -1.27B -492M -6.22B -475M -465M -19.95B
Net Debt 116B 85.91M 76.33M 71.24M 64.93M 122M 8.26B 124M 862M 334M 4.22B 323M 316M 13.55B 177B 132M 117M 109M 99.43M 188M 12.65B 189M 1.32B 512M 6.46B 494M 483M 20.75B
Logo Aprogen Biologics Inc.
Aprogen Biologics Inc, formerly Aprogen Pharmaceuticals Inc, is a Korea-based company principally engaged in the pharmaceutical business. The Company operates its business through two segments. The Medicine Business segment is engaged in the manufacture and sale of central nervous system drugs, autonomic agents, arteriosclerosis agents, metabolic agents, circulatory system drugs, biopharmaceuticals and others. The Segment is also engaged in the manufacture and sale of cosmetics such as skin moisturizers and others. The Gaming Business segment is engaged in the development and operation of role-playing games (RPGs).
Employees
262
Date Price Change Volume
26-10-02 ₩1,564.00 +1.03% 199,501
26-10-01 ₩1,548.00 +5.31% 164,250
26-09-30 ₩1,470.00 -2.46% 164,231
26-09-29 ₩1,507.00 -3.89% 230,861
  1. Stock Market
  2. Stocks
  3. A003060 Stock